Personal Information

First Name: *

Please enter first name

Family Name: *

Please enter family name

Email: *

Please enter email address Email is not in correct format

Country: *

Please select country.. Austria Belgium Bulgaria Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Ireland Italy Latvia Lithuania Luxembourg Malta Netherlands Poland Portugal Romania Slovakia Slovenia Spain Sweden Iceland Liechtenstein Norway Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Darussalam Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Côte d’Ivoire Croatia Cuba Democratic Republic of the Congo Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Eritrea Ethiopia Faeroe Islands Falkland Islands Fiji French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Ghana Gibraltar Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hong Kong India Indonesia Iran, Islamic Republic of Iraq Israel Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kosovo Kuwait Kyrgyzstan Laos Lebanon Lesotho Liberia Libya Macau Madagascar Malawi Malaysia Maldives Mali Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Macedonia Northern Marianas Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Islands Puerto Rico Qatar Réunion Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines San Marino São Tomé and Príncipe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America United States Minor Outlying Islands Uruguay US Virgin Islands Uzbekistan Vanuatu Vatican City Venezuela Viet Nam Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Please select country

Note: The published comments will not contain personal information

 Comments

ECHA accepts no responsibility or liability with regard to the information (including attachments) submitted through the webform.

Instructions:

1. Comments submitted through this webform should be non-confidential and will be published on ECHA’s website. Non-confidential attachments are also published on ECHA’s website.
2. Do not submit attachments without highlighting the relevance of the attached document in the commenting box. Attachments sent without an accompanying comment may not be possible to take into account.
3. If you submit a confidential attachment, please also provide a version with confidential parts removed/blanked out, which will be published on ECHA’s website.
4. Umbrella organisations are recommended to submit one set of comments/attachments during the consultation phase on behalf of the member companies/organisations, rather than individual companies/organisations submitting the same comments separately.
5. Please submit comments/information on the hazard classes open for consultation as indicated on ECHA’s website, and in the commenting fields below. In developing its opinion, RAC may consider another category more appropriate for the classification of the substance after examining the available information in the CLH report, its annexes and information received during the consultation. You are therefore encouraged to also give support for a proposal you agree to. Arguments on why a higher or lower classification is or is not appropriate are appreciated.
6. Results of toxicological and ecotoxicological studies, and other information listed in Article 119 of the REACH Regulation, as read together with Article 38(2) of the CLP Regulation, cannot be claimed confidential. Information claimed confidential not in line with these provisions may not be taken into account if the confidentially claim prevents the publication of the justification of the opinion.
7. The CLH report will not be updated following the consultation. Therefore, comments related to language, typographical errors or editorial changes to the text of the report may not be relevant.

*		I understand that it is my responsibility not to include confidential information in responses to general comments and in any responses to requests for specific information (e.g. company name, email addresses, phone numbers, signatures etc.). ECHA will not be held liable for any damages caused by making non confidential responses publicly available.
Please mark the checkbox to indicate that you understand your responsibilities regarding confidential information.

General Comments - use this field for non-hazard class related comments

Where relevant, please add the reference to the page or section of the CLH report your comment refers to Do not use characters < >

Comments on the open hazard classes:

Physical hazards:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Acute toxicity:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Skin corrosion/irritation:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Serious eye damage/eye irritation:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Respiratory sensitisation:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Skin sensitisation:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Mutagenicity:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Carcinogenicity:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Reproductive toxicity:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Specific target organ toxicity – single exposure:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Specific target organ toxicity – repeated exposure:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to
Hazardous to the aquatic environment:	Where relevant, please add the reference to the page or section of the CLH report your comment refers to

 Public attachment

Upload Attachment:

This information can be made publicly available. Please highlight the relevance of the attached document and the supportlive information in the comment boxes above. Add attachment Maximum file size is 10 MB Maximum file size is 10 MB No attachment selected. File type is not valid. No attachment selected. File type is not valid. If you would like to submit more than one document, please create a zip archive where you include all files and upload the zip file as attachment. Maximum file size is 10 MB.

*		I have removed/blanked the information I want to keep/I have claimed confidential from all the attachments (for example: company name, company logo, if claimed confidential, personal data, signatures, and confidential business data). I have also highlighted the relevance of the attached document in the commenting box. I understand that ECHA will not be held liable for any damages caused by making the attachments publicly available.
Please mark the checkbox that you have removed confidential information from attachments.

 Confidential attachment

Upload Attachment:

This information will only be made available to the Member State competent authority submitting the CLH dossier, ECHA, its Committees and the European Commission. If the dossier submitter is a manufacturer, importer or downstream user, confidential information will not be provided to them. Add attachment Maximum file size is 10 MB Maximum file size is 10 MB No attachment selected. File type is not valid. No attachment selected. File type is not valid. If you would like to submit more than one document, please create a zip archive where you include all files and upload the zip file as attachment. Maximum file size is 10 MB.

*		A redacted version of this confidential attachment is provided in the Public attachment section or a summary is included in the relevant comment box. Results of toxicological and ecotoxicological studies, and other information listed in Article 119 of the REACH Regulation, as read together with Article 38(2) of the CLP Regulation, cannot be claimed confidential. Information claimed confidential not in line with these provisions may not be taken into account if the confidentially claim prevents the publication of the justification of the opinion.
Please mark the checkbox that a non-confidential version of the document was provided.

 Information on the CLH process

The comments received will be compiled in a response to comments document (RCOM), and provided to the dossier submitter and the Committee for Risk Assessment (RAC) along with the attachments submitted during the commenting phase.

If the dossier submitter is a manufacturer, importer or downstream user, confidential attachments will not be provided to them. The dossier submitter and RAC will be providing their response to the comments in the RCOM document.

Please be aware that submitting any information/comments after the consultation is not possible. Any relevant on-going studies should be mentioned during the consultation. However, please note that the CLH processes cannot be put on hold until the finalisation of these studies.

If the substance is an active ingredient in a plant protection product (PPP) or biocidal product (BP), comments submitted in this consultation may be used in the PPP/BP processes, and, comments received for the PPP/BP processes may be used in the CLH process.

By submitting any information and documents through the webform, you guarantee that you hold all necessary rights with regard to the information provided, including but not limited to copyright where applicable, and therefore that you are entitled to submit this information for the purposes listed herein and for its use by ECHA, including its committees. By submitting this information, you also agree that the submitted comments will be put on ECHA’s website on a regular basis during the consultation, and this may be subject to third party comments. Supportive information provided as non-confidential attachments are also published on ECHA’s website.

Please note that if an access to documents application according to Regulation (EC) No 1049/2001 on public access to documents is received regarding this information, ECHA will have to first assess the content of this information before defining its position. Therefore, you are invited to indicate below any reason for which disclosure of this information should be denied. Please note that ECHA can only examine reasons appearing in Article 4 of Regulation (EC) No 1049/2001 on public access to documents as valid.

Under Article 4(1) and (2) of the Access to Documents Regulation (Regulation (EC) No 1049/2001), several reasons are outlined as to why information submitted as confidential cannot be disclosed to persons requesting access to documents.

In the commenting field below, please explain your reasons why the documents submitted as confidential should not be disclosed if we receive a request for access to the documents. (A reason could be that the protection of your commercial interests, including intellectual property, would be undermined).

No confidential information of any kind should be included: Do not use characters < >

The information submitted through this webform is used solely for the purpose of the CLH process and, where applicable, for plant protection product or biocidal product processes. The legal basis for the processing is found in Article 37(4) of Regulation (EC) No 1272/2008 on the classification, labelling and packaging of substances and mixtures (CLP Regulation).

The European Chemicals Agency will ensure on its part that your personal data is processed as required by Regulation (EC) No 45/2001 on the protection of personal data.

Any individual submitting personal data to ECHA is entitled to access and rectify that data. To exercise this right contact the data controller at classification@echa.europa.eu. Furthermore, you also have the right to recourse to ECHA’s Data Protection Officer (data-protection-officer@echa.europa.eu) or to the European Data Protection Supervisor.